Cargando…
Achieving a high cure rate with direct‐acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi‐clinic demonstration project
OBJECTIVES: Highly effective direct‐acting antivirals (DAAs) for Hepatitis C treatment are largely inaccessible in sub‐Saharan Africa. Data on treatment feasibility and outcomes in clinical settings are limited. We assessed the feasibility of achieving a high (≥90%) cure rate with DAAs in six gastro...
Autores principales: | Coyer, Liza, Njoya, Oudou, Njouom, Richard, Mossus, Tatiana, Kowo, Mathurin Pierre, Essomba, Frida, Boers, Alexander, Coutinho, Roel, Ondoa, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540389/ https://www.ncbi.nlm.nih.gov/pubmed/32502290 http://dx.doi.org/10.1111/tmi.13450 |
Ejemplares similares
-
Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon
por: Andoulo, Firmin Ankouane, et al.
Publicado: (2014) -
Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon
por: Yengo, Clauvis Kunkeng, et al.
Publicado: (2020) -
Seroprevalence of hepatitis B and associated factors among inmates: a cross sectional study in the Douala New Bell Prison, Cameroon
por: Kowo, Mathurin Pierre, et al.
Publicado: (2021) -
Evaluating the performance of a rapid antigen test for the detection of influenza virus in clinical specimens from children in Cameroon
por: Kenmoe, Sebastien, et al.
Publicado: (2014) -
The first 30 days of COVID-19 vaccination in Cameroon: achievements, challenges, and lessons learned
por: Amani, Adidja, et al.
Publicado: (2022)